Screener
Core Scientific, Inc. CORZ Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Core Scientific, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The source filing: Core Scientific, Inc.’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 7:08 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001839341-26-000014
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Principal payments on debt | — | (8,613) |
| Other financing activities | 158 | (495) |
| Net cash provided by (used in) financing activities | 3,191,955 | (35,970) |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 2,240,013 | (255,635) |
| Cash, cash equivalents and restricted cash—beginning of period | 311,378 | 836,980 |
| Cash, cash equivalents and restricted cash—end of period | $2,551,391 | $581,345 |
| Supplemental disclosure of other cash flow information: | ||
| Cash paid for interest, net of capitalized interest | $12,846 | $8,386 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Core Scientific, Inc.'s net change in cash?
- Core Scientific, Inc. (CORZ) reported net change in cash of $1.41B in Q2 2026.
- How has Core Scientific, Inc.'s net change in cash changed year-over-year?
- Core Scientific, Inc.'s net change in cash increased by 1297.3% year-over-year, from -$117.38M to $1.41B.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.
Ask your AI about Core Scientific, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude